Clinical Trial Update: Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating safety, dose tolerance, pharmacokinetics, and pharmacodynamics of CPX-POM in patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CPX-POM

Snippet

Sponsor: CicloMed LLC | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2021-11-17